Install
PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- 5,366articles · 30d
- 11+ hour agolatest article
- Aug 15, 2026earliest in window
- 92%with images
- 272avg words
- Economy, Business & Finance 2,519
- Finance & Business 2,005
- News 1,340
- Business & Industrial 709
- Science & Technology 598
- Health & Wellness 547
- Medical 519
- Arts, Culture, Entertainment & Media 456
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
18+ hour, 2+ min ago (405+ words) 14 Sep, 2026, 06:56 CST MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Pixclara® (floretyrosine F 18 or 18F-FET),…...
Foundation Fighting Blindness Renames Venture Philanthropy Arm the Gund Vision Fund, Honoring Five Decades of Gund Family Leadership
4+ day, 10+ min ago (441+ words) PR Newswire The new name honors the decades of leadership and giving by Foundation co-founder Gordon Gund and his family, honoring the Fund's evolution into one of the most innovative venture philanthropy models in the retinal disease market COLUMBIA, Md. and…...
ObvioHealth and SPRIM PRO Launch Integrated Digital Patient Monitoring and Clinical Support Solution for High-Risk Therapies
4+ day, 2+ hour ago (157+ words) Sep 10, 2026, 10:00 ET As pharmaceutical pipelines continue to evolve toward specialty medicines, biologics, cell and gene therapies, and other high-risk treatments, sponsors are seeking new approaches to deliver the clinical oversight these therapies require while reducing burden on patients, healthcare providers,…...
The Galien Foundation Announces Nominees for the Inaugural 2026 Prix Galien Patient First Award in Honor of Michael J. Fox
4+ day, 8+ min ago (1037+ words) Sep 10, 2026, 12:50 ET New Award Category Honors Excellence in Clinical Research, Clinical Trials, and Patient-Centered Care Improvement Initiatives at 20th Anniversary of Prix Galien USA Inaugural Prix Galien Patient First Award in Honor of Michael J. Fox (Nominees) - Private-Sector Initiatives Sickle Cell Warriors…...
HealthWell Foundation Announces Panel Session at the NASP inSPire 2026 Specialty Pharmacy Conference
4+ day, 3+ hour ago (310+ words) PR Newswire ROCKVILLE, Md., Sept. 10, 2026 /PRNewswire/ -- The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans, is pleased to announce a panel presentation at NASP's inSPire 2026 to be held September 22-25, 2026, in National Harbor, Maryland. From Policy…...
QUANTA DIALYSIS TECHNOLOGIES, INC. TO BE HONORED AT PREMIER, INC.'S ANNUAL SUPPLIER INNOVATION CELEBRATION
4+ day, 3+ hour ago (501+ words) PR Newswire BEVERLY, Mass., Sept. 10, 2026 /PRNewswire/ -- Quanta Dialysis Technologies® today announced that it will be honored during Premier's annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, which is scheduled to take place October 6-8 at the Gaylord National Resort…...
NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE
4+ day, 3+ hour ago (325+ words) Sep 10, 2026, 09:00 ET SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference,…...
Q'Apel Medical Announces U.S. Launch of the Lynx™ Aspiration Catheter System
5+ day, 2+ hour ago (481+ words) PR Newswire - Company expands its neurovascular portfolio and broadens its offering for stroke intervention - Marks the second product to feature its proprietary Q'Apel Laser Cut Tube (QLCT™) technology FREMONT, Calif., Sept. 9, 2026 /PRNewswire/ -- Q'Apel Medical (Q'Apel), an innovator in neurovascular intervention,…...
Marquis Who's Who Honors Monib A. Zirvi, MD, PhD, for Excellence in Dermatology
4+ day, 21+ hour ago (233+ words) Sep 09, 2026, 15:39 ET UNIONDALE, N.Y., Sept. 9, 2026 /PRNewswire/ -- Marquis Who's Who announces the inclusion of Monib A. Zirvi, MD, PhD, in its biographical volumes in recognition of his more than two decades of contributions to dermatology, medical research and patient care. Since joining Summit…...
1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia
5+ day, 4+ hour ago (134+ words) Sep 09, 2026, 08:00 ET OC-3 is a potentially best-in-class PARP1 inhibitor for cancers that are defective in DNA homologous recombination repair 1cBio to receive up to US$27 million in upfront, development and potential sales milestone payments The 1cBio agreement with Lee's Pharm provides a valued…...